Landos Biopharma Inc. (LABP)
NASDAQ: LABP
· Real-Time Price · USD
22.93
0.13 (0.57%)
At close: May 23, 2024, 10:00 PM
Landos Biopharma Ratios and Metrics
Financials in USD. Fiscal
year is
January - December.
Fiscal Year | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
Period Ending | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
PE Ratio | -3.77 | -0.93 | -1.03 | -1.67 | -0.86 | -1.3 | -0.82 | -0.65 | -1 | -2.4 | -11.57 | 23.71 | -6.39 |
PEG Ratio | -0.08 | -0.17 | -0.02 | 0.06 | 0.08 | 0.03 | 0.03 | 0.03 | 0.03 | -0.04 | 0.03 | -0.18 | -0.21 |
PS Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -10.73 | n/a | 21.59 | n/a |
PB Ratio | 5.79 | 0.71 | 0.64 | 0.60 | 0.41 | 0.51 | 0.59 | 0.57 | 0.96 | 2.53 | 6.21 | 3.68 | 2.48 |
P/FCF Ratio | -15.78 | -4.57 | -10.81 | -5.11 | -2.37 | -5.43 | -3.39 | -1.63 | -3.6 | -16.07 | -48.19 | 42.00 | -19.89 |
P/OCF Ratio | -15.78 | -4.57 | -10.81 | -5.11 | -2.37 | -5.44 | -3.46 | -1.63 | -3.6 | -16.02 | -49.26 | 41.33 | -19.99 |
OCF/S Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.67 | n/a | 0.52 | n/a |
Debt / Equity Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 0.00 | n/a | n/a | n/a | n/a |
Quick Ratio | 4.43 | 6.09 | 7.77 | 15.35 | 12.30 | 7.39 | 9.04 | 8.92 | 4.99 | 5.55 | 9.40 | 9.40 | 12.44 |
Current Ratio | 4.43 | 6.09 | 7.77 | 15.35 | 12.30 | 7.39 | 9.04 | 8.92 | 4.99 | 5.55 | 9.40 | 9.40 | 12.44 |
Asset Turnover | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | -0.19 | n/a | 0.15 | n/a |
Interest Coverage | n/a | -11.56 | n/a | -7.97 | n/a | n/a | -116.85 | n/a | n/a | -63.74 | -64.94 | n/a | n/a |
Return on Equity | -0.38 | -0.19 | -0.16 | -0.09 | -0.12 | -0.1 | -0.18 | -0.22 | -0.24 | -0.26 | -0.13 | 0.04 | -0.1 |
Return on Assets | -0.3 | -0.16 | -0.14 | -0.08 | -0.11 | -0.09 | -0.16 | -0.19 | -0.19 | -0.22 | -0.12 | 0.03 | -0.09 |
Return on Invested Capital | -0.4 | -0.2 | -0.14 | -0.1 | -0.13 | -0.12 | -0.18 | -0.22 | -0.24 | -0.27 | -0.13 | 0.04 | -0.1 |
Dividend Yield | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Payout Ratio | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Gross Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.00 | n/a | 1.00 | n/a |
Net Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.12 | n/a | 0.23 | n/a |
Pretax Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.12 | n/a | 0.23 | n/a |
Operating Profit Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.13 | n/a | 0.22 | n/a |
FCF Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
EBITDA Margin | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 1.13 | n/a | 0.22 | n/a |